Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review

Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review

BackgroundHyper-immunoglobulin E (IgE) syndromes (HIES) are a group of primary immune deficiencies disorders (PID) characterized by elevated serum IgE, eczema, recurrent skin, or respiratory system infections and may also be accompanied by some connective tissues and skeletal abnormalities. Currentl...

Full description

Bibliographic Details
Main Authors: Jun Lan, Yi Zhang, Min Song, Shan Cai, Hong Luo, Ruoyun OuYang, Pan Yang, Xiaoliu Shi, Yingjiao Long, Yan Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Medicine
Subjects:
hyper-IgE syndrome
STAT3 gene
allergy bronchopulmonary aspergillosis
omalizumab
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.835257/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.835257/full

Similar Items